Report calls for major changes in drug-approval process, but will they be implemented?

Robinson, Alex
February 1993
CMAJ: Canadian Medical Association Journal;2/1/1993, Vol. 148 Issue 3, p432
Academic Journal
No abstract available.


Related Articles

  • Single NDA for world use soon? Dickinson, James G. // Medical Marketing & Media;Sep97, Vol. 32 Issue 9, p28 

    Reports on the decision of participants at the 1997 International Conference on Harmonization to adopt as a major project a final design of a common mechanical document for drug-approval submissions. Completion of nine harmonized guidances and an international medical dictionary for regulatory...

  • Dateline Washington. Coorsh, Richard // Consumers' Research Magazine;Aug98, Vol. 81 Issue 8, p6 

    Reports that in 1998 the number of prescription drugs withdrawn from the market has nearly matched the number of prescription drugs banned over the past decade. Drugs which were withdrawn; Details on the drug-approval process.

  • The Side Effects of truth. Scherer, Michael // Mother Jones;May/Jun2005, Vol. 30 Issue 3, p71 

    Reports on the conflict between U.S. Food and Drug Administration (FDA) researcher doctor David Graham and the FDA following the disclosure of a threat posed by Vioxx, a class of painkillers called Cox-2 inhibitors from Merck. Information on the drug-approval process in the country; Personal...

  • Bill would shake up FDA's drug-approval process. Aston, Geri // AHA News;2/26/96, Vol. 32 Issue 8, p3 

    Reports on a legislation in the United States design to overhaul the US Food and Drug Administration's drug-approval process in terms of off-label medicines. Expected benefits of the legislation; Apprehensions over the bill's approval. INSET: Reform bill's steps to speedy drug approvals, by G.A..

  • Summary of Drug-Approval Process in the U.S.  // Caribbean Business;6/23/2005, Vol. 33 Issue 24, pP8 

    Focuses on the summary of drug-approval process in the U.S. Preclinical research; Clinical research; Food and Drug Administration review and approval; Marketing.

  • FDA criticized for dangerous leniency. Dove, Alan // Nature Medicine;Jun2002, Vol. 8 Issue 6, p542 

    Informs that researchers at Harvard Medical School in association with Washington-based advocacy group Public Citizen accused that drug-approval process of the U.S. Food and Drug Administration (FDA) allows dangerous compounds to reach patients. Response of FDA and pharmaceutical industry to...

  • FDA Scientists Concerned Over Drug Safety.  // BioPharm International;Jan2005, Vol. 18 Issue 1, p12 

    Reports on findings of a 2002 survey by the Health and Human Services Office of Inspector General, which showed that U.S. Food and Drug Administration (FDA) have doubts about the drug-approval, labeling and postmarket-monitoring processes. Percent of FDA scientists who reported being pressured...

  • Microarrays: Standards and practices. E., M. // Nature;8/31/2006, Vol. 442 Issue 7106, p1067 

    The article features the FDA's launch of the MicroArray Quality Control (MAQC) project aimed at helping the drug-approval process. The MAQC is a collabotative effort of research leaders from government, academia and industry to establish tightly controlled 'gold standard' comparisons of...

  • Safety drill.  // Tufts University Diet & Nutrition Letter;Mar95, Vol. 13 Issue 1, p2 

    Reports on a bill proposed by the United States Department of Agriculture calling for sweeping changes in the monitoring of slaughterhouses and meat processing plants. Delay in implementation after approval of the proposed bill.

  • WHY COMPUTERS IN EDUCATION MAY FAIL. Stevens, Dorothy Jo // Education;Summer84, Vol. 104 Issue 4, p370 

    Research findings reported in this article provides information that will assist principals to effectively implement the change process necessary to maximize the success of computer usage in classrooms. Qualified staff, adequate hardware and support materials are major components of the change...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics